- Home
- RXT vs LXEO Comparison
RXT vs LXEO Comparison
Compare RXT & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- LXEO
- Stock Information
- Founded
- RXT 1998
- LXEO 2017
- Country
- RXT United States
- LXEO United States
- Employees
- RXT N/A
- LXEO N/A
- Industry
- RXT EDP Services
- LXEO
- Sector
- RXT Technology
- LXEO
- Exchange
- RXT Nasdaq
- LXEO Nasdaq
- Market Cap
- RXT 280.1M
- LXEO 290.5M
- IPO Year
- RXT 2020
- LXEO 2023
- Fundamental
- Price
- RXT $1.39
- LXEO $6.77
- Analyst Decision
- RXT Hold
- LXEO Strong Buy
- Analyst Count
- RXT 5
- LXEO 7
- Target Price
- RXT $1.58
- LXEO $15.29
- AVG Volume (30 Days)
- RXT 1.1M
- LXEO 782.4K
- Earning Date
- RXT 11-11-2025
- LXEO 11-12-2025
- Dividend Yield
- RXT N/A
- LXEO N/A
- EPS Growth
- RXT N/A
- LXEO N/A
- EPS
- RXT N/A
- LXEO N/A
- Revenue
- RXT $2,693,100,000.00
- LXEO N/A
- Revenue This Year
- RXT N/A
- LXEO N/A
- Revenue Next Year
- RXT $1.59
- LXEO N/A
- P/E Ratio
- RXT N/A
- LXEO N/A
- Revenue Growth
- RXT N/A
- LXEO N/A
- 52 Week Low
- RXT $1.00
- LXEO $1.45
- 52 Week High
- RXT $3.41
- LXEO $11.72
- Technical
- Relative Strength Index (RSI)
- RXT 50.52
- LXEO 78.63
- Support Level
- RXT $1.41
- LXEO $4.95
- Resistance Level
- RXT $1.53
- LXEO $7.40
- Average True Range (ATR)
- RXT 0.08
- LXEO 0.48
- MACD
- RXT -0.00
- LXEO 0.14
- Stochastic Oscillator
- RXT 33.33
- LXEO 74.80
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.